Real-world evidence of the effects of sodium-glucose co-transporter 2 inhibitors on the dosing of diuretics in patients with heart failure: a retrospective cohort study

Real-world evidence of the effects of sodium-glucose co-transporter 2 inhibitors on the dosing of diuretics in patients with heart failure: a retrospective cohort study

Background: Heart failure (HF) was estimated to impact approximately 64 million individuals worldwide in 2017 and is predicted to rise in the coming years. Therefore, the aim of our study was to evaluate the effects of sodium-glucose transport protein 2 (SGLT2) inhibitors on the dosing of diuretics...

Full description

Bibliographic Details
Main Authors: Abdulaziz Alsalem, Mohammed M. Alsultan, Faisal Alqarni, Abdullah Almangour, Lolwa Alsharekh, Saleem Alenazi, Saleh Alzahrani, Raghad A. Almanqour, Abdullah Alazmi, Abdullah Alzahrani
Format: Article
Language:English
Published: Frontiers Media S.A. 2024-04-01
Series:Frontiers in Pharmacology
Subjects:
SGLT2 inhibitors
diuretics
heart failure
dapagliflozin
cardiovascular disease
Online Access:https://www.frontiersin.org/articles/10.3389/fphar.2024.1366439/full

Internet

https://www.frontiersin.org/articles/10.3389/fphar.2024.1366439/full

Similar Items